Naturhouse Health (NTH) AI Stock Analysis

• Market Cap: €155.27M
• Dividend Yield: 11.15%
• Average Volume (3M): 24.74K
• Price to Earnings (P/E): 9.4
• Beta (1Y): 0.17
• Revenue Growth: -4.18%
• EPS Growth: 4.98%
• Country: ES
• Employees: 191
• Sector: Healthcare
• Sector Strength: 45
• Industry: Packaged Foods
• EPS (TTM): 0.16
• Shares Outstanding: 60,000,000
• 10 Day Avg. Volume: 17,416
• 30 Day Avg. Volume: 24,740
• PEG Ratio: 0.00
• Price to Book (P/B): 4.53
• Price to Sales (P/S): 8.87
• P/FCF Ratio: 32.03
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.15
• Revenue Forecast (FY): €48.10M

• Rating: 70 Outperform
• Price Target: €3.00 ▲(30.43% Upside)
• Action: Reiterated Date: 04/09/26
• Date: Action: Reiterated 04/09/26

The score is driven primarily by solid financial fundamentals (strong profitability, cash flow, and low leverage) but tempered by a severe 2025 revenue decline and reduced equity. Valuation is attractive (low P/E and high dividend yield), while technicals show a stable uptrend with only moderate momentum.

Positive Factors

High profitability and margins

Consistently high EBIT and net margins demonstrate that Naturhouse converts revenue into durable earnings efficiently. Strong margins provide a structural earnings buffer against top-line softness, enable internal funding for dividends or investment, and help sustain cash flows during cyclical or competitive pressure.

Negative Factors

Steep multi-year revenue decline

A persistent top-line contraction culminating in -37.9% in 2025 undermines long-term earnings durability. Even with strong margins, shrinking revenue reduces scale economics in centers and product sales, constrains growth options, and raises the risk that profits and cash flow will be harder to sustain over time.

Naturhouse Health Business Overview & Revenue Model

Company Description

Naturhouse Health (NTH) is a global leader in the health and wellness sector, specializing in nutritional counseling and weight management solutions. The company operates through a franchise model, providing its clients with personalized dietary p...

Read more

Naturhouse Health (NTH) is a global leader in the health and wellness sector, specializing in nutritional counseling and weight management solutions. The company operates through a franchise model, providing its clients with personalized dietary p...

How the Company Makes Money

NTH primarily makes money through (1) retail sales of its own nutrition and diet-related products to clients attending Naturhouse centers and (2) fees and economics derived from operating a branded center network (notably via franchising). In prac...

Read more

NTH primarily makes money through (1) retail sales of its own nutrition and diet-related products to clients attending Naturhouse centers and (2) fees and economics derived from operating a branded center network (notably via franchising). In prac...

Naturhouse Health Financial Statement Overview

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	47.81M	47.63M	49.42M	50.41M	52.40M	57.59M
Gross Profit	34.47M	12.94M	35.46M	25.11M	37.48M	41.26M
EBITDA	13.43M	14.45M	15.63M	17.93M	15.61M	20.80M
Net Income	10.23M	10.09M	9.86M	11.29M	9.63M	13.36M
Balance Sheet
Total Assets	43.70M	33.43M	42.59M	48.85M	42.82M	49.00M
Cash, Cash Equivalents and Short-Term Investments	23.34M	14.57M	21.67M	27.10M	14.78M	27.25M
Total Debt	2.72M	3.35M	4.27M	5.05M	5.38M	4.37M
Total Liabilities	17.86M	15.68M	10.91M	18.21M	14.96M	12.92M
Stockholders Equity	25.83M	17.75M	31.68M	30.63M	27.81M	36.02M
Cash Flow
Free Cash Flow	10.91M	11.48M	11.22M	20.38M	6.13M	16.12M
Operating Cash Flow	11.64M	12.15M	11.56M	20.95M	7.10M	16.17M
Investing Cash Flow	163.00K	-420.00K	862.00K	-459.00K	-5.22M	-4.27M
Financing Cash Flow	-14.92M	-18.95M	-16.10M	-7.70M	-16.98M	-6.27M

Naturhouse Health Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.30
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:NTH, the sentiment is Positive. The current price of 2.3 is below the 20-day moving average (MA) of 2.56, below the 50-day MA of 2.54, and above the 200-day MA of 2.11, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 56.30 is Neutral, neither overbought nor oversold. The STOCH value of 73.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ES:NTH.

Naturhouse Health Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PUIG	71 Outperform	€9.85B	14.11	15.69%	―	―	―
NTH	70 Outperform	€155.27M	9.45	38.28%	11.15%	-4.18%	4.98%
EBRO	66 Neutral	€2.89B	13.19	9.45%	3.50%	-0.42%	-3.34%
DIA	57 Neutral	€2.41B	16.50	1180.47%	―	5.97%	―
OLE	55 Neutral	€147.00M	9.57	-13.27%	―	-1.52%	-116.80%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
PVA	42 Neutral	€7.30M	-82.11	―	―	―	―